BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aurobindo Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524804
ISIN Demat
INE406A01037
Book Value (Rs)
369.1611632
NSE Symbol
AUROPHARMA
Divident Yield %
0
Market Cap
(Rs In Cr.)
76,303
P/E (TTM)
35.59
EPS (TTM)
36.91
Face Value
(Rs)
1
Back
Board of Aurobindo Pharma approves PPA with Garuda Renewables
09-Feb-26   Hrs IST

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved to enter into a power purchase agreement with Garuda Renewables, to procure renewable energy from hybrid sources of wind and solar and in this connection the Company will be investing Rs. 66 crores for acquiring upto 26% stake in Garuda Renewables.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)